Abstract:Protein Arginine Methyltransferases (PRMTs) are a family of enzymes regulating protein arginine methylation, which is a post-translational modification crucial for various cellular processes. Recent studies have highlighted the mechanistic role of PRMTs in cancer pathogenesis, immunotherapy, and drug resistance. PRMTs are involved in diverse oncogenic processes, including cell proliferation, apoptosis, and metastasis. They exert their effects by methylation of histones, transcription factors, and other regulatory proteins, resulting in altered gene expression patterns. PRMT-mediated histone methylation can lead to aberrant chromatin remodeling and epigenetic changes that drive oncogenesis. Additionally, PRMTs can directly interact with key signaling pathways involved in cancer progression, such as the PI3K/Akt and MAPK pathways, thereby modulating cell survival and proliferation. In the context of cancer immunotherapy, PRMTs have emerged as critical regulators of immune responses. They modulate immune checkpoint molecules, including programmed cell death protein 1 (PD-1), through arginine methylation. Drug resistance is a significant challenge in cancer treatment, and PRMTs have been implicated in this phenomenon. PRMTs can contribute to drug resistance through multiple mechanisms, including the epigenetic regulation of drug efflux pumps, altered DNA damage repair, and modulation of cell survival pathways. In conclusion, PRMTs play critical roles in cancer pathogenesis, immunotherapy, and drug resistance. In this overview, we have endeavored to illuminate the mechanistic intricacies of PRMT-mediated processes. Shedding light on these aspects will offer valuable insights into the fundamental biology of cancer and establish PRMTs as promising therapeutic targets.

The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond

The Structure and Functions of PRMT5 in Human Diseases

Substrate Specificity, Processivity, and Kinetic Mechanism of Protein Arginine Methyltransferase 5

PRMT5 in gene regulation and hematologic malignancies

Versatility of PRMT5-induced methylation in growth control and development

The Where and the How of PRMT5

PRMT5 function and targeting in cancer

Proteomics Profiling of Arginine Methylation Defines PRMT5 Substrate Specificity

Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)

Protein arginine methylation: from enigmatic functions to therapeutic targeting

Protein Arginine Methyltransferase 5: a Potential Cancer Therapeutic Target

Crystal structure of the human PRMT5:MEP50 complex

PRMT7: A Pivotal Arginine Methyltransferase in Stem Cells and Development

Protein Arginine Methyltransferases (PRMTs): Orchestrators of Cancer Pathogenesis, Immunotherapy Dynamics, and Drug Resistance

The role of protein arginine methylation 5 in DNA damage repair and cancer therapy

PRMT5: a putative oncogene and therapeutic target in prostate cancer

Medicinal chemistry strategies targeting PRMT5 for cancer therapy.

Protein arginine methylation of non-histone proteins and its role in diseases.

The methylation induced by protein arginine methyltransferase 5 promotes tumorigenesis and progression of lung cancer

Medicinal chemistry insights into PRMT5 inhibitors

The Methylation Induced by Protein Arginine Methyltransferase 5 Promotes Tumorigenesis and Progression of Lung Cancer.